The state of California is suing three big pharmaceutical companies as well as three pharmacy benefit managers, alleging that all of them collude to drive up insulin prices in an abuse of market power.
Eli Lilly, Novo Nordisk, and Sanofi, are the three drug companies named in the…
Source: medcitynews.com – Read more